Viewing Study NCT04809220

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2026-01-28 @ 7:44 PM
Study NCT ID: NCT04809220
Status: COMPLETED
Last Update Posted: 2024-05-22
First Post: 2021-03-19
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus View
None Diabetes Mellitus, Type 2 View
None Glucose Metabolism Disorders View
None Metabolic Disease View
None Endocrine System Diseases View
None Hypoglycemic Agents View
None Type 2 Diabetes Mellitus (T2DM) View
Keywords: